Preferential inhibition of DNA polymerases α, δ, and ε from Novikoff hepatoma cells by inhibitors of cell proliferation

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 2, 1996, Pages 78-94

  Fox, Gabriele ^a   Popanda, Odilia ^a   Edler, Lutz ^a   Thielmann, Heinz Walter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Catalytic domains of DNA polymerases; Mutant DNA polymerases; Mutator properties; Physico chemical constants of DNA polymerases; Rat liver

Indexed keywords

AMSACRINE; APHIDICOLIN; CAMPTOTHECIN; CARBONYLDIPHOSPHATE; CONGOCIDINE; COUMAMYCIN; DAUNORUBICIN; DISTAMYCIN A; DNA DIRECTED DNA POLYMERASE; DOXORUBICIN; ETHIDIUM BROMIDE; MEPACRINE; MITOXANTRONE; NOVOBIOCIN; TOPOTECAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; NOVIKOFF HEPATOMA; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DNA PRIMERS; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA-DIRECTED DNA POLYMERASE; ENZYME INHIBITORS; FEMALE; KINETICS; LIVER NEOPLASMS, EXPERIMENTAL; POLY DA-DT; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; TEMPLATES, GENETIC; THYMUS GLAND; TUMOR CELLS, CULTURED;

EID: 0030029818     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01226265     Document Type: Article

References (66)

1. Basra J, Wolf CR, Brown JR, Patterson LH (1985) Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone. Anticancer Drug Des 1:45-52
2. Bosch K (1086) Angewandte Statistik: Einführung in Problemlösungen mit dem Mikrocomputer. Vieweg, Braunschweig
3. Boyer JC, Thomas DC, Maher VM, McCormick JJ, Kunkel TA (1993) Fidelity of DNA replication by extracts of normal and malignantly transformed human cells. Cancer Res 53:3270-3275
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Byrnes JJ, Downey KM, Esserman L, So AG (1975) Mechanism of hemin inhibition of erythroid cytoplasmic DNA polymerase. Biochemistry 14:796-799
6. Byrnes JJ, Downey KM, Black VL, So AG (1976) A new mammalian DNA polymerase with 3′ to 5′ exonuclease activity: DNA polymerase δ. Biochemistry 15:2817-2823
7. Byrnes JJ, Downey KM, Que BG, Lee MYW, Black VL, So AG (1977) Selective inhibition of the 3′ to 5′ exonuclease activity associated with DNA polymerases: a mechanism of mutagenesis. Biochemistry 16:3740-3746
8. Chan JYH, Becker FF (1979) Decreased fidelity of DNA polymerase activity during N-2-fluorenylacetamide hepatocarcinogenesis. Proc Natl Acad Sci USA 76:814-818
9. Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF (1984) Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259:13560-13566
10. Chuang LF, Chuang RY, Acton EM, Israel M, Yu M (1987) Effect of morpholinyladriamycin analogs and adriamycin on the activities of DNA polymerase α and RNA polymerase II of chicken leukemia cells. J Pharmacol Exp Ther 242:372-377
11. Chung DW, Zhang J, Tan C-K, Davie EW, So AG, Downey KM (1991) Primary structure of the catalytic subunit of human DNA polymerase δ and chromosomal location of the gene. Proc Natl Acad Sci USA 88:11197-11201
12. Copeland WC, Lam NK, Wang TS-F (1993) Fidelity studies of the human DNA polymerase α. J Biol Chem 268:11041-11049
13. DePhilipp RM, Lynch WE, Lieberman I (1977) Nuclear DNA polymerases of human carcinomas. Cancer Res 37:702-704
14. Dohashi Y, Shuin T, Tsuruga H, Uemura H, Torigoe S, Kubota Y (1994) DNA polymerase β gene mutation in human prostate cancer. Cancer Res 54:2827-2829
15. Durchschlag H (1986) Specific volumes of biological macromolecules and some other molecules of biological interest. In: Hinz H-J (ed) Thermodynamic data for biochemistry and biotechnology. Springer, Berlin Heidelberg New York, pp 45-128
16. Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS (1989) In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 49:1541-1547
17. Farber E (1992) On cells of origin of liver cell cancer. In: Sirica AE (ed) The role of cell types in hepatocarcinogenesis. CRC, Boca Raton, Fla, pp 1-28
18. Fry M, Loeb LA (eds) (1986) Animal cell DNA polymerases. CRC, Boca Raton, Fla
19. Goulian M, Herrmann SM, Sackett JW, Grimm SL (1990) Two forms of DNA polymerase δ from mouse cells. J Biol Chem 265:16402-16411
20. Hsiang Y-H, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerasr I. J Biol Chem 260:14873-14878
21. Hübscher U, Thömmes P (1992) DNA polymerase ε: in search of a function. Trends Biochem Sci 17:55-58
22. Hussy P, Maass B, Tümmler B, Grosse F, Schomburg U (1986) Effect of 4-quinolones and novobiocin on call thymus DNA polymerase α primase complex, topoisomerase I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother 29:1073-1078
23. Jaxel C, Kohn KW, Wani MC, Wall ME, Pommier Y (1989) Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res 49:1465-1469
24. Kapscinski J, Darzynkiewicz Z, Traganos F, Melamed MR (1981) Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxy-ethyl)amino]ethyl]amino]-9,10- anthracenedione, with nucleic acids. Biochem Pharmacol 30:231-240
25. Karnasuta C, Dunsford HA, Schmidt WN, Sell S (1987) Monoclonal antibodies identify oval cells as possible precursor of hepatocellular carcinoma during azo dye carcinogenesis. Fed Proc 46:746
26. Kesti T, Frantti H, Syväoja JE (1993) Molecular cloning of the cDNA for the catalytic subunit of human DNA polymerase ε. J Biol Chem 268:10238-10245
27. Kopka ML, Yoon C, Goodsell D, Pjura P, Dickerson RE (1985) The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc Natl Acad Sci USA 82:1376-1380
28. Lerman LS (1963) The structure of the DNA-acridine complex. Biochemistry 49:94-102
29. Levy A, Weisman-Shomer P, Fry M (1989) Distamycin paradoxically stimulates the copying of oligo(dA)·poly(dT) by DNA polymerases. Biochemistry 28:7262-7267
30. Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658-666
31. Liu LF, Miller KG (1981) Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc Natl Acad Sci USA 78:3487-3491
32. Liu PK, Chang C-C, Trosko JE, Dube DK, Martin GM, Loeb LA (1983) Mammalian mutator mutant with an aphidicolin-resistant DNA polymerase α. Proc Natl Acad Sci USA 80:797-801
33. Liu PK, Trujillo JM, Monnat RJ (1993) Spectrum of spontaneous mutation in animal cells containing an aphidicolin-resistant DNA polymerase α. Mutat Res 288:229-236
34. Loch LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079
35. Momparler RL, Karon M, Siegel SE, Avila F (1976) Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res 36:2891-2895
36. Montecucco A, Fontana M, Focher F, Lestingi M, Spadari S, Ciarrocchi G (1991) Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity. Nucleic Acids Res 19:1067-1072
37. Müller H, Klingert A (1993) Surface interpolation from cross sections. In: Hagen H, Müller G, Nielson GM (eds) Focus on scientific visualization. Springer, Berlin Heidelberg New York, pp 145-196
38. Nasheuer H-P, Moore A, Wahl AF, Wang TS-F (1991) Cell cycle-dependent phosphorylation of human DNA polymerase α. J Biol Chem 266:7893-7903
39. Neidle S, Pearl LH, Skelly JV (1987) DNA structure and perturbation by drug binding. Biochem J 243:1-13
40. Novikoff AB (1957) A lransplantable rat liver tumor induced by 4-dimethylaminoazobenzene. Cancer Res 17:1010-1027
41. Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46:2203-2207
42. m. In: Pahlich E (ed) Geschwindigkeitskontrolle von Stoffwechselabläufen. Vieweg, Braunschweig, pp 70-72
43. Podust V, Bialek G, Sternbach H, Grosse F (1990) Casein kinase II phosphorylates DNA-polymerase-α-DNA-primase without affecting its basic enzymic properties. Eur J Biochem 193:189-193
44. Popanda O, Thielmann HW (1989) DNA polymerase α from normal rat liver is different than DNA polymerases α from Morris hepatoma strains. Eur J Biochem 183:5-13
45. Popanda O, Thielmann HW (1992) The function of DNA topoisomerases in UV-induced DNA excision repair: studies with specific inhibitors in permeabilized human fibroblasts. Carcinogenesis 13:2321-2328
46. Popanda O, Fox G, Thielmann HW (1995) DNA polymerases α, δ, and ε of Novikoff hepatoma cells differ from those of normal rat liver in physicochemical and catalytic properties. J Mol Med 73:259-268
47. Schmidt WN, Page DL, Schmidt CA, McKusick KB, Ward WS, Hnilica LS (1984) Characterization of monoclonal antibodies to Novikoff hepatoma cytokeratin antigen p39. Cancer Res 44:5867-5879
48. Schmidt WN, Page DL, McKusick K, Hnilica LS (1985) Cell specificity of rat cytokeratin p39 during azo dye-induced hepatocarcinogenesis. Carcinogenesis 6:1147-1153
49. Sell S (1990) Is there a liver stem cell? Cancer Res 50:3811-3815
50. Siegel LM, Monty KJ (1966) Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases. Biochim Biophys Acta 112:346-362
51. Springgate CF, Loeb LA (1973) Mutagenic DNA polymerase in human leukemic cells. Proc Natl Acad Sci USA 70:245-249
52. Sugino A, Higgins NP, Brown PO, Peebles CL, Cozzarelli NR (1978) Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc Natl Acad Sci USA 75:4838-4842
53. Syväoja J, Suomensaari S, Nishida C, Goldsmith JS, Chui GSJ, Jain S, Linn S (1990) DNA polymerases α, δ and ε: three distinct enzyms from HeLa cells. Proc Natl Acad Sci USA 87:6664-6668
54. Talanian RV, Brown NC, McKenna CE, Ye T-G, Levy JN, Wright GE (1989) Carbonyldiphosphonate, a selective inhibitor of mammalian DNA polymerase δ. Biochemistry 28:8270-8274
55. Tan C-K, Castillo C, So AS, Downey KM (1986) An auxiliary protein for DNA polymerases-δ from fetal calf thymus. J Biol Chem 261:12310-12316
56. Tanaka M, Yoshida S (1980) Mechanism of the inhibition of calf thymus DNA polymerases α and β by daunomycin and adriamycin. J Biochem (Tokyo) 87:911-918
57. Tsurimoto T, Melendy T, Stillman B (1990) Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin. Nature 346:534-539
58. Wang L, Patel U, Lagnajita G, Banerjee S (1992) DNA polymerase β mutations in human colorectal cancer. Cancer Res 52:4824-4827
59. Wang TS-F (1991) Eukaryotic DNA polymerases. Annu Rev Biochem 60:513-552
60. Wang TS-F, Hu S-Z, Korn D (1984) DNA primase from KB cells: characterization of a primase activity tightly associated with immunoaffinity purified DNA polymerase α. J Biol Chem 259: 1854-1865
61. Wang TS-F, Wong SW, Korn D (1989) Human DNA polymerase α: predicted functional domains and relationships with viral DNA polymerases. FASEB J 3:14-21
62. Weiser T, Gassmann M, Thömmes P, Ferrari E, Hafkemeyer P, Hübscher U (1991) Biochemical and functional comparison of DNA polymerases α, δ, and ε from calf thymus. J Biol Chem 266:10420-10428
63. Wong SW, Wahl AF, Yuan P-M, Arai N, Pearson BE, Arai K, Korn D, Hunkapiller MW, Wang TSF (1988) Human DNA polymerase 2 gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases. EMBO J 7:37-47
64. Yang C-L, Zhang S-J, Toomey NL, Palmer TN, Lee MYWT (1991) Induction of DNA polymerase activities in the regenerating rat liver. Biochemistry 30:7534-7541
65. Zimmer C, Wähnert U (1986) Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog Biophys Mol Biol 47:31-112
66. Zunino F, Di Marco A, Zaccara A, Gambetta RA (1980) The interaction of daunorubicin and doxorubicin with DNA and chromatin. Biochim Biophys Acta 607:206-214